Wyeth Paying $491M To End Criminal, Civil Rapamune Cases

By Megan Stride · July 30, 2013, 5:44 PM EDT

Wyeth Pharmaceuticals Inc. has agreed to shell out $491 million to end a criminal action as well as civil False Claims Act cases alleging it illegally marketed its immunosuppressive drug Rapamune...

To view the full article, register now.